Recent updates on COVID-19: A holistic review

Coronaviruses are large positive-sense RNA viruses with spike-like peplomers on their surface. The Coronaviridae family's strains infect different animals and are popularly associated with several outbreaks, namely SARS and MERS epidemic. COVID-19 is one such recent outbreak caused by SARS-CoV-2 identified first in Wuhan, China. COVID-19 was declared a pandemic by WHO on 11th March 2020. Our review provides information covering various facets of the disease starting from its origin, transmission, mutations in the virus to pathophysiological changes in the host upon infection followed by diagnostics and possible therapeutics available to tackle the situation. We have highlighted the zoonotic origin of SARS-CoV-2, known to share 96.2% nucleotide similarity with bat coronavirus. Notably, several mutations in SARS-CoV-2 spike protein, nucleocapsid protein, PLpro, and ORF3a are reported across the globe. These mutations could alter the usual receptor binding function, fusion process with the host cell, virus replication, and the virus's assembly. Therefore, studying these mutations could help understand the virus's virulence properties and design suitable therapeutics. Moreover, the aggravated immune response to COVID-19 can be fatal. Hypertension, diabetes, and cardiovascular diseases are comorbidities substantially associated with SARS-CoV-2 infection. The review article discusses these aspects, stating the importance of various comorbidities in disease outcomes. Furthermore, medications' unavailability compels the clinicians to opt for atypical drugs like remdesivir, chloroquine, etc. The current diagnostics of COVID-19 include qRT-PCR, CT scan, serological tests, etc. We have described these aspects to expose the information to the scientific community and to accelerate the research..

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:6

Enthalten in:

Heliyon - 6(2020), 12, Seite e05706-

Sprache:

Englisch

Beteiligte Personen:

Shweta Jakhmola [VerfasserIn]
Omkar Indari [VerfasserIn]
Dharmendra Kashyap [VerfasserIn]
Nidhi Varshney [VerfasserIn]
Annu Rani [VerfasserIn]
Charu Sonkar [VerfasserIn]
Budhadev Baral [VerfasserIn]
Sayantani Chatterjee [VerfasserIn]
Ayan Das [VerfasserIn]
Rajesh Kumar [VerfasserIn]
Hem Chandra Jha [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.sciencedirect.com [kostenfrei]
Journal toc [kostenfrei]

Themen:

Epidemiology
Health disparity
Microbiology
Science (General)
Social sciences (General)
Vaccines
Virology
Viruses

doi:

10.1016/j.heliyon.2020.e05706

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ074263978